Frequently Asked Questions From Potential EUCYT Patients
So just what is a stem cell?
Stem cells are human cells with the unique ability to develop into specialized cell types in the body.
- They can divide repeatedly to produce new cells
- As they divide, they can change into the other types of cells that make up the body
- Stem cells can be used to replace lost or damaged cells that our bodies can’t replace naturally
- They’ve been used to rebuild tendons, cartilage, muscles and bones
What is regenerative medicine?
This biotherapeutic solution uses a body’s stem cells to help correct problems such as joint, ligament, cartilage and muscle injuries, and chronic diseases such as diabetes.
Who is the primary candidate for such treatments?
Anyone suffering with joint, ligament, cartilage and muscle injuries and chronic illnesses.
Does insurance cover the procedure? If not, what is the cost?
As regenerative medicine is still a relatively new treatment option, many insurance companies don’t yet cover these therapies. However, as they can be less expensive than surgery or chronic medications, stem cell solutions are becoming more commonly covered by insurance. Out of pocket expenses depend on the exact nature of the medical procedure.
Given my diagnosis of, for example, knee cartilage loss, what can you do to make my healing experience less expensive than typical solutions such as repetitive cortisone shots or surgery?
Stem cell injections or patches don’t generally require anesthesia, surgery or long recovery times. All make for a more pleasant recovery.
What are the average rates of recovery compared to traditional programs?
No two patients recover the same. Recovery times are significantly influenced by comorbid illness(es) which often effect(s) where cellular migration is most needed for the body. Also, the influence of alcohol, tobacco and caffeine can inhibit the longevity of both a person’s own stem cells as well as the donated stem cells.
What are the potential risks/complications associated with injections?
- Infection at injection site
- Swelling and pain at injection site
- Irritation from the carrier solutions that contain the stem cells
However, these risks are low and often resolve spontaneously.
How long is the procedure? Is there downtime?
The stem cell injection takes only minutes and downtime is negligible compared to surgery. Though every patient is different, average downtime is days versus weeks.
Do I need to do anything prior to the procedure?
- AVOID ALCOHOL, TOBACCO and limit caffeine intake to one cup daily
- Vitamin supplementation prior to a procedure has been shown to improve longevity of donor stem cells
Are there any ethical concerns with using stem cell tissue?
Though the tissues are isolated after a planned, full-term, healthy birth without risk to mother or child, it’s each individual’s personal choice as to whether these stem cell solutions are right for you. But basically, these options don’t have the same ethical concerns as embryonic or fetal-cell options.
Is there a possibility for disease transmission from EUCYT’s products?
There is a small risk, but donor eligibility is carefully determined, and the cells are tested for more than 15 infectious diseases and must be negative or non-reactive. Testing is performed by a CLIA-certified lab. A Certificate of Analysis can be provided to show test results.
What are the standards for donation? How is cord blood tested?
Each candidate undergoes comprehensive screening. which includes evaluations of their health, medical history and behavioral risks (smoking, sexual activity, travel, etc.). They are tested for infectious diseases, specifically: HIV, hepatitis B and C, T-cell lymphotropic virus, syphilis, and cytomegalovirus. In addition, we test the finished product for sterility, serology, and blood typing. All screenings and evaluations take place under the supervision of a medical director. All processing is done at an FDA-registered, CLIA-registered laboratory. Our products are regulated under 21 CFR 1271, and, in particular, 21 CFR 1271.10. (human cells, tissues, and cellular and tissue-based products or “HCT/P”). The extraction and processing methods utilized by EUCYT reduces the loss of structural proteins, cytokines and growth factors. The product is minimally manipulated and intended for homologous use, as defined in United States Food and Drug Administration requirements for Human Cellular and Tissue based Products (HCT/P), 21 CFR 1271, and guidelines of the American Association of Tissue Banks (AATB).
Can I provide my own stem cells for a procedure versus having to use a donor?
Yes, contact EUCYT to inquire how.
How is EUCYT different from other donation centers?
Our staff is highly trained with years of experience in cord-blood processing. The extraction and processing methods used by EUCYT reduces the loss of structural proteins, cytokines and growth factors. The product is minimally manipulated and intended for homologous use, as defined in FDA requirements for Human Cellular and Tissue based Products (HCT/P), 21 CFR 1271, and guidelines of the American Association of Tissue Banks (AATB).
Where is cell processing done?
All screenings and evaluations are undertaken with the supervision of a Medical Director. All processing is done at an FDA registered, CLIA-certified laboratory. All products are regulated under 21 C.F.R. 1271, in its entirety, and, in particular, 21 C.F.R. 1271.10 as human cells, tissues, and cellular and tissue-based product(s) (HCT/Ps).
What are the qualifications to be a donor?
Maternal donors are determined eligible by the EUCYT medical director, after review of prescreening evaluations and test results. Blood test results, donor medical history, behavioral and social risk assessment, physical assessment, and information from family medical histories are used to determine that the tissue is acceptable for transplantation. All donations are unpaid and completely voluntary.
Is donating safe?
Donors are screened and evaluated for medical and behavioral risk factors and communicable diseases, with microbiological testing of the finished products. Every product can be traced to the day and time of tissue processing and to the individual donor. All screenings and evaluations are undertaken with the supervision of a EUCYT medical director. All processing is done at an FDA-registered, CLIA-certified laboratory. Products are regulated under 21 C.F.R. 1271 in its entirety, and, in particular, 21 C.F.R. 1271.10 as human cells, tissues, and cellular and tissue-based product(s) (HCT/Ps).